Proposal for a predictive model of erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
- 28 February 2013
- journal article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 25 (4) , 121-126
Abstract
To determine the risk factors for EDin men treated by prostate brachytherapy (PB) for localized prostate cancer and to propose a model to predict post-implant erectile function. Out of a series of 270 sexually active men treated by PB, 241 (89%) (mean age=66 years (range, 43-80)) accepted to participate in a mail-based study on erectile function. The risk factors for erectile dysfunction were determined by regression analysis and a predictive model was proposed. The performance of the model was determined in this population and subsequently verified in a population of 50 men treated by PB in another treatment center. The risk factors for ED after PB were age, the pre-implant IIEF score and prostate volume. In the studied population, the final model to predict a post-treatment IIEF-5 score, using these factors, had a sensitivity of 69% and a specificity of 68% associated to an area under the ROC curve (AUC) of 0.75. The same performance was obtained in another treatment center. Age, pre-implant IIEF-5 score and prostate volume may be used to predict post-implant erectile function in patients treated by PB.Keywords
This publication has 24 references indexed in Scilit:
- Predictive models of toxicity with external radiotherapy for prostate cancerCancer, 2009
- Ejaculatory Function After Permanent 125I Prostate Brachytherapy for Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- A Population-Based, Longitudinal Study of Erectile Dysfunction and Future Coronary Artery DiseaseMayo Clinic Proceedings, 2009
- Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lowerCancer, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile functionBJU International, 2006
- Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: Potential influence of sexual motivation and/or indifferenceUrology, 2006
- The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experienceInternational Journal Of Impotence Research, 2005
- Sexuality after Treatment for Early Prostate Cancer. Exploring the Meanings of "Erectile Dysfunction"Journal of General Internal Medicine, 2001
- PENILE ERECTILE FUNCTION AFTER PERMANENT RADIOACTIVE SEED IMPLANTATION FOR TREATMENT OF PROSTATE CANCERJournal of Urology, 2001